A study by former Junior Associate Professor Kazuo Takayama, currently a professor of the Institute of Science Tokyo, ...

"Nirsevimab is highly effective in preventing RSV-related outcomes in infants, with a pooled real-world effectiveness of 83 ...

For example, during SARS-CoV-2 infection, both T and B lymphocytes play critical roles in viral clearance and the generation ...

FILE - This electron microscope image provided by the National Institutes of Health shows human respiratory syncytial virus (RSV ... shedding from the surface of human lung cells. (National Institute ...

By Stephanie Brown HealthDay ReporterFRIDAY, May 2, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services ...

The U.S. Department of Health and Human Services and the National Institutes of Health made an announcement of the latest ...

The seasonal timing of when infants receive the new respiratory syncytial virus (RSV) immunization is crucial for ensuring ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

Specifically, cytotoxic T cells target infected cells ... For respiratory conditions like influenza and Respiratory Syncytial Virus (RSV), mRNA vaccines offer faster adaptability to viral ...